India Ratings & Research (Ind-Ra) has affirmed Shilpa Medicare Limited’s long-term issuer rating at ‘IND A+’. The rating on fund-based working capital limits Rs3,450 million (increased from Rs2,450 million) has been affirmed at IND A+/Stable/IND A1.
The credit rating agency has also affirmed ratings on the Term loans with maturity date of March 2026 Rs3,352.2 million (increased from Rs3,093.8 million) at IND A+/Stable.
At around 9.22 am, Shilpa Medicare Ltd was trading at Rs394.05 per piece up by Rs6.75 or 1.74% from its previous closing of Rs387.30 per piece on the BSE.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.